Sandoz Group AG (SDZNY)

Market Cap	33.94B +74.4%
Revenue (ttm)	11.16B +7.4%
Net Income	914.00M
EPS	2.09
Shares Out	n/a
PE Ratio	37.13
Forward PE	19.19
Dividend	0.57 (0.70%)
Ex-Dividend Date	Apr 22, 2025

Volume	21,223
Average Volume	53,696
Open	78.06
Previous Close	78.23
Day's Range	77.77 - 79.30
52-Week Range	35.61 - 94.15
Beta	0.33
RSI	38.23
Earnings Date	Feb 25, 2026

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1886
• Employees: 22,356
• Stock Exchange: OTCMKTS
• Ticker Symbol: SDZNY